Headlines Orasis Raises $30M for Presbyopia Treatment Bluestem Capital and Visionary Ventures led the financing round. Published 1 week ago on September 10, 2020 By INVISION Staff Share Tweet HERZLIYA, ISRAEL — Orasis Pharmaceuticals, an ophthalmic pharmaceutical company working on a treatment for presbyopia symptoms, has closed on $30 million in financing. The Series C financing was co-led by new investor Bluestem Capital and returning investor Visionary Ventures. Also participating were other returning investors Sequoia Capital, SBI (Japan) Innovation Ventures, Maverick Ventures Israel, LifeSci Venture Partners and additional investors. Tyler J. Stowater, partner and vice president of Bluestem Capital, will join the Orasis board of directors in conjunction with the financing. INVISION Podcast Podcast: Talking with the Finest, Hippest of Them All About Why There are No Ball Point Pens in Her Shop INVISION Podcast Licensed or Not, Member or Not, the Opticians Association of America is Here for You [Podcast] INVISION Podcast Drs. Adam Ramsey and Darryl Glover Talk About Fostering Relationships Between Black ECPs and the Industry at Large Proceeds from the financing will be used to advance Orasis’ lead eye drop candidate for the treatment of presbyopia symptoms through completion of its Phase 3 clinical trials. The funds will also be used for pre-commercialization activities ahead of potential product launch. “This successful funding round completes the capitalization for the Phase 3 clinical trials and fuels the initial growth strategy for commercialization,” said Elad Kedar, CEO of Orasis. “We aspire to make near vision clear again for people with presbyopia by empowering them with an unparalleled solution, an eye drop that will provide them with comfort and control of their near vision. We are very grateful for and highly encouraged by the validation from a diverse range of investors, including the co-lead investors Bluestem Capital and Visionary Ventures, and our returning investors. Our product candidate has demonstrated excellent efficacy, safety and comfort profiles in previous clinical studies and we look forward to initiating our Phase 3 clinical trials to further evaluate the effectiveness of the product in the near future.” Tyler J. Stowater, partner and vice president of Bluestem, added, “With almost 2 billion people in the world living with presbyopia, the market potential for a novel, non-invasive option is highly anticipated by eyecare providers and patients. We have high confidence in the Orasis team, to successfully complete its clinical program, and apply their informed commercial approach, which will make Orasis a leader in the presbyopia space.” Advertisement Related Topics:Latest News Toppresbyopia click to Comment(Comment) Up Next Vision Council Unveils New Brand Identity Don't Miss Small-Business Owners Growing Increasingly Pessimistic on COVID-19, Says NRF Advertisement SPONSORED VIDEO SPONSORED BY SHAMIR Shamir Glacier PLUS™UV Utilizing the most advanced technologies, Shamir Glacier PLUS™ UV ensures you receive the most enhanced performance from your lenses. You may like TikTok for the Modern Eye Doc MetLife to Acquire Versant Health, Owner of Davis Vision and Superior Vision, in $1.68B Deal PECAA Partners with Optometry Practice Valuations Promoted Headlines Introducing EssilorLuxottica 360 Essilor American Eyes 2020 — Safilo’s Celebration of U.S. Eye Care Professionals Continues Safilo Introducing C Life by Champion L'Amy Advertisement Latest Trending Videos Columns22 hours ago TikTok for the Modern Eye Doc Headlines1 day ago MetLife to Acquire Versant Health, Owner of Davis Vision and Superior Vision, in $1.68B Deal Press Releases1 day ago PECAA Partners with Optometry Practice Valuations Press Releases2 days ago Max Mara Eyewear Enters the Marcolin Group Portfolio Press Releases2 days ago World Leaders in Consumer Electronics and Health Care to Announce Blue Light Summit 2020 Photo Gallery4 days ago The Frame Within the Frame … and More Fiendishly Brilliant Home Eyewear Repairs From Your Clients Headlines3 weeks ago Warby Parker Gets $245M in Funding Headlines3 weeks ago VSP Ventures Acquires 6 California Optometry Practices Photo Gallery1 week ago 16 Images That Show Why ‘Uptown Eyes’ in Fayetteville, AR, Was Named One of America’s Finest Optical Retailers Headlines2 weeks ago VSP Global Names President for VSP Ventures Sponsored Content4 days ago Introducing EssilorLuxottica 360 Sponsored Webinars4 weeks ago Introducing Varilux® Comfort Max Lenses Headlines4 weeks ago Video: Gandhi’s Eyeglasses Could Fetch $19K+ at Auction INVISION Podcast2 months ago Podcast: Talking with the Finest, Hippest of Them All About Why There are No Ball Point Pens in Her Shop Headlines3 months ago Video: 11 ODs Share Their Stories of Being Black in America Advertisement SubscribeBULLETINS Get the most important news and business ideas for eyecare professionals every weekday from INVISION. Advertisement Most Popular Photo Gallery4 days ago The Frame Within the Frame … and More Fiendishly Brilliant Home Eyewear Repairs From Your Clients Cover Stories3 days ago Don’t Do It! 44 Things an ECP Should Just Never Do Headlines2 days ago EssilorLuxottica and Facebook to Collaborate on Smartglasses Headlines1 week ago Small-Business Owners Growing Increasingly Pessimistic on COVID-19, Says NRF Buzz Session4 days ago We Wanted to Know Your Favorite Social Media Accounts to Follow and Boy Did You Deliver Do You Or Don't You1 week ago Well More Than Half of You Say It’s Important to Manage Your Google My Business Page Products1 week ago Representation Matters and These 9 Alternative Fit Frames Are Here For It True Tales5 days ago A Patient Insists These Are Not Her Glasses and Someone Switched Them!